Cancer Investigation

SJR Rank #12,015H-index: 97SJR: 0.495Best quartile: Q3
Journal website: aims, scope and author guidelines
Publisher

Taylor & Francis Group LLC Philadelphia

Country

United States

Type

journal

SJR by Edition

2022202500.150.30.450.6

Subject Categories

  • Medicine (miscellaneous)Q3
  • OncologyQ3
  • Cancer ResearchQ4

Areas: Biochemistry, Genetics and Molecular Biology · Medicine

Most published research topics

Cancer Treatment and PharmacologyLung Cancer Treatments and MutationsColorectal Cancer Treatments and StudiesLymphoma Diagnosis and TreatmentBreast Cancer Treatment StudiesCancer-related Molecular PathwaysImmunotherapy and Immune ResponsesHER2/EGFR in Cancer ResearchCancer Genomics and DiagnosticsLung Cancer Research Studies

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs065130195260

Documents per Year

202220250255075100

Detailed Information

ISSN

0735-7907, 1532-4192

SJR Best Quartile

Q3

Region

Northern America

Citations per Document (2 years)

1.90

References per Document

49.06

Coverage

1983-2026

Scope

Cancer Investigation is one of the most highly regarded and recognized journals in the field of basic and clinical oncology. It is designed to give physicians a comprehensive resource on the current state of progress in the cancer field as well as a broad background of reliable information necessary for effective decision making. In addition to presenting original papers of fundamental significance, it also publishes reviews, essays, specialized presentations of controversies, considerations of new technologies and their applications to specific laboratory problems, discussions of public issues, miniseries on major topics, new and experimental drugs and therapies, and an innovative letters to the editor section. One of the unique features of the journal is its departmentalized editorial sections reporting on more than 30 subject categories covering the broad spectrum of specialized areas that together comprise the field of oncology. Edited by leading physicians and research scientists, these sections make Cancer Investigation the prime resource for clinicians seeking to make sense of the sometimes-overwhelming amount of information available throughout the field. In addition to its peer-reviewed clinical research, the journal also features translational studies that bridge the gap between the laboratory and the clinic.

Metrics from SCImago Journal Rank 2025. View on SCImago